Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of increased doses of
lopinavir/ritonavir (LPV/r) and saquinavir (SQV) in HIV infected children who are failing
their current antiretroviral regimen
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)